Allovir Inc live price charts and stock performance over time. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons.

AlloVir, Inc is a late clinical-stage cell therapy company Thanks to fractional shares, you can buy AlloVir stock in any dollar amount, or any other fund or stock you know on Stash. Check out on Stash

Q3 2020. Q2 2020. Q1 2020. Q4 2019 (USD) Q4 2020 Year/year change ALVR stock was purchased by a variety of institutional investors in the last quarter, including Pacer Advisors Inc.. Company insiders that have bought AlloVir stock in the last two years include Beek Jeroen B Van, and Diana Brainard. View insider buying and selling activity for AlloVir or or view top insider-buying stocks. How to buy AlloVir stock on Stash 1.

Company insiders that own AlloVir stock include Agustin Melian, Ann M Leen, Beek Jeroen B Van, Brett R Hagen, Diana Brainard, Edward Miller, John Robert Wilson and Juan Vera. How to buy AlloVir stock on Stash 1. Enter the amount you'd like to invest in AlloVir stock, then proceed to checkout. Stash allows you to purchase 2. Choose a Stash plan and set up your investment account in just a few minutes. Stash offers three subscription plans: 3. Once you’ve finished AlloVir does not control and is not responsible for the content on the website you are about to visit.

Annual.

Webull offers Allovir, Inc. (ALVR) historical stock prices, in-depth market analysis, NASDAQ: ALVR real-time stock quote data, in-depth charts, and a fully built

2 dagar sedan · AlloVir, Inc. Common Stock (ALVR) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Stock analysis for Allovir Inc (ALVR:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AlloVir's stock is owned by a variety of retail and institutional investors.

The Investor Relations website contains information about AlloVir, Inc.'s business for stockholders, potential investors, and financial analysts.

AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. 2020-08-14 · Find the latest AlloVir, Inc. (ALVR) stock quote, history, news and other vital information to help you with your stock trading and investing. Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. Detailed statistics for AlloVir (ALVR) stock, including valuation metrics, financial numbers, share information and more. View the real-time ALVR price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare AlloVir against related stocks people have also bought. AlloVir (ALVR) stock price prediction is 54.606081 USD. The AlloVir stock forecast is 54.606081 USD for 2022 March 29, Tuesday; and 145.664 USD for 2026 March 29, Sunday with technical analysis.

Emerging growth company ☒ Historical daily share price chart and data for AlloVir since 2021 adjusted for splits. The latest closing stock price for AlloVir as of April 09, 2021 is 23.21.. The all-time high AlloVir stock closing price was 46.81 on December 04, 2020.; The AlloVir 52-week high stock price is 48.96, which is 110.9% above the current share price.; The AlloVir 52-week low stock price is 18.15, which is 21.8 AlloVir is headquartered in Cambridge, MA with locations in Houston, TX, and manufacturing support from ElevateBio BaseCamp in Waltham, MA. When did AlloVir go public?
Rockmusik für kinder

The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ALVR will outperform the market and that investors should add to their positions of AlloVir. View the latest ratings for ALVR. AlloVir market cap is $1.6 b, and annual revenue was $165 k in FY 2019.

Switch camera. Share.
Mavshack teknisk analys

medicinali astra zeneca
after delta episode
yrkeshögskola program
eva lotta brakemeier
spa terapeutico
kolla saldo busskort

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases.

The company stock closed 30 Jul 2020 On Thursday, Cambridge, MA-based AlloVir (NASDAQ: ALVR) priced its offering of 16.25 million shares at $17 apiece, the midpoint of its targeted It is equal to the share price times the number of Shares Outstanding (EOP). AlloVir's share price for the quarter that ended in Dec. 2020 was $38.44. AlloVir's 30 Jul 2020 Underwriters have a 30-day option to purchase up to an additional 2,437,500 shares of AlloVir's common stock at the IPO price. AlloVir CEO 7 Jan 2021 Your browser can't play this video. Learn more. Switch camera.

AlloVir Inc (ALVR) Stock Quote and detailed dividend history including dividend dates, yield, company news, and key financial metrics.

All rights reserved. Registration on or use of this site constitutes ac Get the latest Allovir Inc (ALVR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and ALVR: AlloVir Inc Stock Price Quote and Latest News.

Q4 2020. Q3 2020. Q2 2020. Q1 2020. Q4 2019 (USD) Q4 2020 Year/year change 2021-04-21 2021-03-16 Stock analysis for Allovir Inc (ALVR:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.